Cargando…

The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma

BACKGROUND: Glioblastoma, the most common primary malignant tumor of the brain, is associated with poor prognosis. Glioblastoma cells exhibit high proliferative and invasive properties, and glioblastoma stem cells (GSCs) have been shown to play a crucial role in the malignant behavior of glioblastom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhiyuan, Wang, Songtao, Yu, Kuo, Chen, Kaile, Zhao, Liang, Zhang, Jiayue, Dai, Kexiang, Zhao, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685699/ https://www.ncbi.nlm.nih.gov/pubmed/38017538 http://dx.doi.org/10.1186/s12967-023-04740-0

Ejemplares similares

Skull base reconstruction using in situ bone flap in patients with pituitary adenomas treated by endoscopic endonasal approach
por: Chen, Kaile, et al.
Publicado: (2023)

Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression
por: Huang, Haidong, et al.
Publicado: (2021)

Oxaliplatin promotes siMAD2L2-induced apoptosis in colon cancer cells
por: Ma, Lu, et al.
Publicado: (2021)

MAD2L2 Promotes Open Chromatin in Embryonic Stem Cells and Derepresses the Dppa3 Locus
por: Rahjouei, Ali, et al.
Publicado: (2017)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
por: Ouyang, Qing, et al.
Publicado: (2015)

MAD2L2 helps mitotic cells take it slow
por: Short, Ben
Publicado: (2013)

Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments
por: Taga, Tetsuya, et al.
Publicado: (2020)

YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma
por: Weng, Junquan, et al.
Publicado: (2022)

Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells
por: Lee, Dae-Hee, et al.
Publicado: (2017)

Mad Poets. No. 2
Publicado: (1879)

LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression
por: Jiang, Xiulin, et al.
Publicado: (2023)

The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma
por: Luo, Haitao, et al.
Publicado: (2023)

Structural activation of Mad2 in the mitotic spindle checkpoint: the two-state Mad2 model versus the Mad2 template model
por: Yu, Hongtao
Publicado: (2006)

Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
por: Ouyang, Qing, et al.
Publicado: (2022)

Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas
por: Toda, Masahiro
Publicado: (2013)

CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma
por: Chuah, You Heng, et al.
Publicado: (2023)

MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation
por: Li, Yixin, et al.
Publicado: (2018)

LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2’-O-methylation
por: Liu, Lihui, et al.
Publicado: (2023)

Research Progress About Glioma Stem Cells in the Immune Microenvironment of Glioma
por: Li, Xiangyu, et al.
Publicado: (2021)

Progress Report from MadAnalysis
por: Conte, Eric
Publicado: (2013)

MAD-X progress and future plans
por: Deniau, L
Publicado: (2012)

Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1–C-Mad2 core complex
por: Hewitt, Laura, et al.
Publicado: (2010)

SHP-2 Activating Mutation Promotes Malignant Biological Behaviors of Glioma Cells
por: Zhao, Yong, et al.
Publicado: (2017)

Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma
por: Shi, Yuan-Xiang, et al.
Publicado: (2016)

Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
por: Zhao, Zheng, et al.
Publicado: (2017)

The two faces of Mad2
por: LeBrasseur, Nicole
Publicado: (2004)

Closing the Mad2 cycle
por: Musacchio, Andrea
Publicado: (2015)

Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma
por: Xia, Tian, et al.
Publicado: (2021)

The Mad2 partial unfolding model: regulating mitosis through Mad2 conformational switching
por: Skinner, John J., et al.
Publicado: (2008)

MAD1L1 Arg558His and MAD2L1 Leu84Met interaction with smoking increase the risk of colorectal cancer
por: Zhong, Rong, et al.
Publicado: (2015)

c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
por: Wang, Jialiang, et al.
Publicado: (2008)

HTML to MadCap Flare: a guide to automating content migration and maintenance
por: Lavin, Peter, et al.
Publicado: (2017)

Coagulation factor 2 thrombin receptor promotes malignancy in glioma under SOX2 regulation
por: Gao, Guojun, et al.
Publicado: (2020)

Mad or mad-mad: conveying subtle emotion with face emoji
por: Upadhyay, Sri Siddhi N., et al.
Publicado: (2023)

MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner
por: Paniagua, Inés, et al.
Publicado: (2022)

Insights into Mad2 Regulation in the Spindle Checkpoint Revealed by the Crystal Structure of the Symmetric Mad2 Dimer
por: Yang, Maojun, et al.
Publicado: (2008)

Maternal genetic polymorphisms in the major mitotic checkpoint genes MAD1L1 and MAD2L1 associated with the risk of survival in abnormal chromosomal fetuses
por: Chan, Ying, et al.
Publicado: (2023)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ra22as2n3dijneg9hmtd4u8662